Read more

August 31, 2020
1 min read
Save

Four institutions join Pediatric Brain Tumor Consortium

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Four institutions have become members of the Pediatric Brain Tumor Consortium.

They are Dana-Farber Cancer Institute, The Hospital for Sick Children, University of Florida and Nationwide Children’s Hospital.

Photo of brain mri
Source: Adobe Stock.

The NCI sponsors and funds the consortium, a multidisciplinary cooperative research organization devoted to the study of correlative tumor biology and new therapies for children with primary central nervous system tumors.

Members of the consortium, established in 1999, share their expertise to develop and conduct novel clinical trials designed to improve treatment of pediatric brain tumors.

New members are chosen through a competitive process based on several characteristics, including clinical trial infrastructure and expertise in basic and translational science.